Oklo Inc. stock moved lower in pre-market trading after the advanced nuclear technology company announced a freshly executed at-the-market equity offering program capable of raising as much as $1 billion through the sale of Class A common stock. The company named ten prominent sales agents to conduct the offering, including Goldman Sachs, BofA Securities, Citigroup, J.P. Morgan, and Morgan Stanley, with fees capped at 1.5% of the gross sales price per share sold.
The newly unveiled ATM replaces an earlier agreement dated May 2026 that Oklo terminated on September 10, 2026 - one day prior to putting the replacement into place. Under the prior program, Oklo sold about 17.97 million shares and collected roughly $1 billion in gross proceeds. The effect of the new facility is to restore the companys capacity to raise a similar scale of capital through share issuance.
For a company still reporting substantial operating losses and without commercial revenue, periodic equity raises are a standing requirement to fund operations. While the additional capital capacity will lengthen Oklos runway, the immediate market reaction was negative. Traders viewed the announcement through a dilution lens, pushing the stock lower in pre-market activity as the market repriced outstanding shares to reflect the potential increase in share count.
That decline in Oklos pre-market price came even as the broader U.S. equity complex traded higher on the day. The S&P 500 gained 0.9%, the Dow rose 1.0%, and the Nasdaq advanced 1.1%. The more constructive tone across major indexes was supported by the August Consumer Price Index report, which showed headline consumer prices up 0.4% month-on-month - broadly in line with expectations and easing some short-term rate concerns ahead of the Federal Reserves next policy decision.
Put together, the episode illustrates a common market dynamic for development-stage companies reliant on recurring equity issuance. The capital-raising mechanism helps support ongoing operations, but market participants typically subtract value from existing shares to account for future dilution once an ATM plan is disclosed. In Oklos case, that repricing occurred despite favorable macroeconomic data that buoyed broader market indices.
Key data points
- New ATM capacity: up to $1 billion via Class A common stock
- Number of sales agents named: ten, including major investment banks
- Commission structure: up to 1.5% of gross sales price per share sold
- Prior ATM outcome: about 17.97 million shares sold for roughly $1 billion in gross proceeds
The announcement underscores a tension that often faces capital-intensive technology and development firms: the practical necessity of dilutive financings to maintain operations, and the near-term negative pressure those financings place on equity prices. The broader markets positive response to inflation data did not prevent investors from negatively revaluing Oklos equity on the news of expanded share-sale capacity.